Amylyx Pharmaceuticals, Inc.

NEW YORK STATE COMMON RETIREMENT FUND AMLX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

21,900

Value ($000)

265

Weight

0.0%

2022 Q1 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	265	0.0%	21,900	12/31/2025
2025 Q3	11/3/2025	298	0.0%	21,900	9/30/2025
2025 Q2	10/8/2025	140	0.0%	21,900	6/30/2025
2024 Q2	10/8/2025	1	0.0%	444	6/30/2024
2024 Q1	10/8/2025	60	0.0%	21,244	3/31/2024
2023 Q4	10/8/2025	350	0.0%	23,754	12/31/2023
2023 Q3	10/8/2025	389	0.0%	21,235	9/30/2023
2023 Q2	10/8/2025	503	0.0%	23,335	6/30/2023
2023 Q1	10/8/2025	784	0.0%	26,731	3/31/2023
2022 Q4	10/8/2025	1,245	0.0%	33,703	12/31/2022
2022 Q3	11/8/2022	659	0.0%	23,406	9/30/2022
2022 Q2	8/4/2022	177	0.0%	9,197	6/30/2022
2022 Q1	7/1/2022	51	0.0%	4,000	3/31/2022